End-stage renal disease and dialysis in HIV-positive patients: Observations from a long-term cohort study with a follow-up of 22 years

HIV Medicine

Volumn 14, Issue 3, 2013, Pages 127-135

  Bickel, M ^a   Marben, W ^a   Betz, C ^a   Khaykin, P ^a   Stephan, C ^a   Gute, P ^b   Haberl, A ^a   Knecht, G ^b   Wolf, T ^a   Brodt, Hr ^a   Geiger, H ^a   Herrmann, E ^a   Jung, O ^a  

^a GOETHE UNIVERSITY   (Germany)

^b Infektiologikum   (Germany)

Author keywords

Chronic kidney disease; Haemodialysis; HIV associated nephropathy; Renal failure; Renal replacement therapy

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ADULT; ARTICLE; CAUCASIAN; CLINICAL OBSERVATION; COHORT ANALYSIS; FEMALE; FOLLOW UP; GERMANY; HEPATITIS C; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; INTRAVENOUS DRUG ABUSE; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; MORTALITY; NEGRO; PREVALENCE; PRIORITY JOURNAL; RENAL REPLACEMENT THERAPY; RETROSPECTIVE STUDY; RISK FACTOR; SURVIVAL;

ADULT; AIDS-ASSOCIATED NEPHROPATHY; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; FEMALE; FOLLOW-UP STUDIES; GERMANY; HEPATITIS C; HIV INFECTIONS; HUMANS; INCIDENCE; KIDNEY FAILURE, CHRONIC; MALE; RENAL DIALYSIS; RENAL REPLACEMENT THERAPY; RETROSPECTIVE STUDIES; RISK FACTORS; SUBSTANCE ABUSE, INTRAVENOUS; TREATMENT OUTCOME;

EID: 84873248243     PISSN: 14642662     EISSN: 14681293     Source Type: Journal    
DOI: 10.1111/j.1468-1293.2012.01045.x     Document Type: Article

References (38)

1. Selik RM, Byers RH Jr, Dworkin MS. Trends in diseases reported on U.S. death certificates that mentioned HIV infection, 1987-1999. J Acquir Immune Defic Syndr 2002; 29: 378-387.
2. Gupta SK, Mamlin BW, Johnson CS, Dollins MD, Topf JM, Dube MP. Prevalence of proteinuria and the development of chronic kidney disease in HIV-infected patients. Clin Nephrol 2004; 61: 1-6.
3. Choi AI, Li Y, Deeks SG, Grunfeld C, Volberding PA, Shlipak MG. Association between kidney function and albuminuria with cardiovascular events in HIV-infected persons. Circulation 2010; 121: 651-658.
4. Wyatt CM, Hoover DR, Shi Q etal. Pre-existing albuminuria predicts AIDS and non-AIDS mortality in women initiating antiretroviral therapy. Antivir Ther 2011; 16: 591-596.
5. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004; 351: 1296-1305.
6. Ahuja TS, Grady J, Khan S. Changing trends in the survival of dialysis patients with human immunodeficiency virus in the United States. J Am Soc Nephrol 2002; 13: 1889-1893.
7. Jotwani V, Li Y, Grunfeld C, Choi AI, Shlipak MG. Risk Factors for ESRD in HIV-infected individuals: traditional and HIV-related factors. Am J Kidney Dis 2012; 59: 628-635.
8. Brown TT, Cole SR, Li X etal. Antiretroviral therapy and the prevalence and incidence of diabetes mellitus in the multicenter AIDS cohort study. Arch Intern Med 2005; 165: 1179-1184.
9. De Wit S, Sabin CA, Weber R etal. Incidence and risk factors for new-onset diabetes in HIV-infected patients: the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) Study. Diabetes Care 2008; 31: 1224-1229.
10. Seaberg EC, Munoz A, Lu M etal. Association between highly active antiretroviral therapy and hypertension in a large cohort of men followed from 1984 to 2003. AIDS 2005; 19: 953-960.
11. Schwartz EJ, Szczech LA, Ross MJ, Klotman ME, Winston JA, Klotman PE. Highly active antiretroviral therapy and the epidemic of HIV+ end-stage renal disease. J Am Soc Nephrol 2005; 16: 2412-2420.
12. Winston JA, Burns GC, Klotman PE. The human immunodeficiency virus (HIV) epidemic and HIV-associated nephropathy. Semin Nephrol 1998; 18: 373-377.
13. Rostand SG, Kirk KA, Rutsky EA, Pate BA. Racial differences in the incidence of treatment for end-stage renal disease. N Engl J Med 1982; 306: 1276-1279.
14. Klag MJ, Whelton PK, Randall BL, Neaton JD, Brancati FL, Stamler J. End-stage renal disease in African-American and white men. 16-year MRFIT findings. JAMA 1997; 277: 1293-1298.
15. Rosset S, Tzur S, Behar DM, Wasser WG, Skorecki K. The population genetics of chronic kidney disease: insights from the MYH9-APOL1 locus. Nat Rev Nephrol 2011; 7: 313-326.
16. Choi AI, Rodriguez RA, Bacchetti P, Bertenthal D, Volberding PA, O'Hare AM. Racial differences in end-stage renal disease rates in HIV infection versus diabetes. J Am Soc Nephrol 2007; 18: 2968-2974.
17. Lucas GM, Lau B, Atta MG, Fine DM, Keruly J, Moore RD. Chronic kidney disease incidence, and progression to end-stage renal disease, in HIV-infected individuals: a tale of two races. J Infect Dis 2008; 197: 1548-1557.
18. Lucas GM, Eustace JA, Sozio S, Mentari EK, Appiah KA, Moore RD. Highly active antiretroviral therapy and the incidence of HIV-1-associated nephropathy: a 12-year cohort study. AIDS 2004; 18: 541-546.
19. Lucas GM, Mehta SH, Atta MG etal. End-stage renal disease and chronic kidney disease in a cohort of African-American HIV-infected and at-risk HIV-seronegative participants followed between 1988 and 2004. AIDS 2007; 21: 2435-2443.
20. Atta MG, Gallant JE, Rahman MH etal. Antiretroviral therapy in the treatment of HIV-associated nephropathy. Nephrol Dial Transplant 2006; 21: 2809-2813.
21. Rodriguez RA, Mendelson M, O'Hare AM, Hsu LC, Schoenfeld P. Determinants of survival among HIV-infected chronic dialysis patients. J Am Soc Nephrol 2003; 14: 1307-1313.
22. Szczech LA, Kalayjian R, Rodriguez R, Gupta S, Coladonato J, Winston J. The clinical characteristics and antiretroviral dosing patterns of HIV-infected patients receiving dialysis. Kidney Int 2003; 63: 2295-2301.
23. th European AIDS Conference. Belgrade, Serbia, October 2011 [Abstract PS7/7].
24. Tourret J, Tostivint I, du Montcel ST etal. Outcome and prognosis factors in HIV-infected hemodialysis patients. Clin J Am Soc Nephrol 2006; 1: 1241-1247.
25. Trullas JC, Barril G, Cofan F etal. Prevalence and clinical characteristics of HIV type 1-infected patients receiving dialysis in Spain: results of a Spanish survey in 2006: GESIDA 48/05 study. AIDS Res Hum Retroviruses 2008; 24: 1229-1235.
26. Bansi L, Hughes A, Bhagani S etal. UK CHIC/ESRF study group. Clinical epidemiology of HIV-associated end-stage renal failure in the UK. AIDS 2009; 23: 2517-2521.
27. Trullas JC, Mocroft A, Cofan F etal. Dialysis and renal transplantation in HIV-infected patients: a European survey. J Acquir Immune Defic Syndr 2010; 55: 582-589.
28. Atta MG, Fine DM, Kirk GD, Mehta SH, Moore RD, Lucas GM. Survival during renal replacement therapy among African Americans infected with HIV type 1 in urban Baltimore, Maryland. Clin Infect Dis 2007; 45: 1625-1632.
29. Frei U, Schober-Halstenberg HJ. Nierenersatztherapie in Deutschland Bericht über Dialysebehandlung und Nierentransplantation in Deutschland. 2006/2007. Available at www.bundesverband-niere.de/files/QuaSi-Niere-Bericht_2006-2007.pdf (accessed 21 August 2012).
30. Wyatt CM, Malvestutto C, Coca SG, Klotman PE, Parikh CR. The impact of hepatitis C virus coinfection on HIV-related kidney disease: a systematic review and meta-analysis. AIDS 2008; 22: 1799-1807.
31. Cheng JT, Anderson HL Jr, Markowitz GS, Appel GB, Pogue VA, D'Agati VD. Hepatitis C virus-associated glomerular disease in patients with human immunodeficiency virus coinfection. J Am Soc Nephrol 1999; 10: 1566-1574.
32. Jaffe JA, Kimmel PL. Chronic nephropathies of cocaine and heroin abuse: a critical review. Clin J Am Soc Nephrol 2006; 1: 655-667.
33. Yanik EL, Lucas GM, Vlahov D, Kirk GD, Mehta SH. HIV and proteinuria in an injection drug user population. Clin J Am Soc Nephrol 2010; 5: 1836-1843.
34. Jung O, Bickel M, Ditting T etal. Hypertension in HIV-1-infected patients and its impact on renal and cardiovascular integrity. Nephrol Dial Transplant 2004; 19: 2250-2258.
35. Szczech LA, Gupta SK, Habash R etal. The clinical epidemiology and course of the spectrum of renal diseases associated with HIV infection. Kidney Int 2004; 66: 1145-1152.
36. Post FA, Campbell LJ, Hamzah L etal. Predictors of renal outcome in HIV-associated nephropathy. Clin Infect Dis 2008; 46: 1282-1289.
37. Krawczyk CS, Holmberg SD, Moorman AC, Gardner LI, McGwin GJ. Factors associated with chronic renal failure in HIV-infected ambulatory patients. AIDS 2004; 18: 2171-2178.
38. Robert Koch Institut - RKI. Aktuelle Daten und Informationen zu Infektionskrankheiten und public health. Epidem Bull 2011; 46: 415-428.